Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder (Q34871885)

5 August 2017

0 references

1 reference

title

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder (English)

1 reference

5 August 2017

0 references

M Kato

1

1 reference

PubMed ID

18982004

5 August 2017

A Serretti

series ordinal

2

1 reference

PubMed ID

18982004

5 August 2017

language of work or name

English

0 references

publication date

4 November 2008

1 reference

5 August 2017

1 reference

5 August 2017

15

1 reference

5 August 2017

5

1 reference

5 August 2017

473-500

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2008.116

5 August 2017

0 references

cites work

Global burden of depressive disorders in the year 2000

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Efficacy of antidepressants in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Tolerability and adherence issues in antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Compliance with medication regimens for mental and physical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Meta-analysis of genetic association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Primary, Secondary, and Meta-Analysis of Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Pharmacogenetic studies in depression: a proposal for methodologic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Meta-analyses of genetic studies on major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Investigation of serotonin-related genes in antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Sequence analysis of the serotonin transporter and associations with antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

No gene is an island: the flip-flop phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The International HapMap Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

5-HT1A receptors, gene repression, and depression: guilt by association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association analysis for the C-1019G promoter variant of the 5-HT1A receptor gene with auditory evoked potentials in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The human 5-HT2 receptor is encoded by a multiple intron-exon gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Fine mapping of the human 5-HTR2a gene to chromosome 13q14 and identification of two highly polymorphic linked markers suitable for association studies in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Molecular cloning of alternatively spliced human 5-HT3 receptor cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The 5-HT3B subunit is a major determinant of serotonin-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Tryptophan hydroxylase-2 controls brain serotonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A functional polymorphism in the monoamine oxidase A gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

SSRIs antidepressant activity is influenced by G beta 3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Functional genomics approaches in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Role of neurotrophic factors in the etiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Schizophrenia genetics: dysbindin under the microscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Neural network analysis in pharmacogenetics of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Optimization of neural network architecture using genetic programming improves detection and modeling of gene-gene interactions in studies of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Religiosity and remission of depression in medically ill older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Identification of true drug response to antidepressants. Use of pattern analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Meta-analyses of the association between genetic polymorphisms of neurotrophic factors and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

HTR2C andHTR1A gene variants in German and Italian suicide attempters and completers

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3----p14 by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

The dysbindin gene in major depression: an association study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.116

7 January 2021

Identifiers

DOI

10.1038/MP.2008.116

1 reference

5 August 2017

1 reference

PubMed ID

18982004